Agilent Technologies Combines Gene Expression, Proteomics and Reagents Businesses into New Life-Sciences Unit
Creation of Integrated Biology Solutions Unit to Fuel Innovation of Technologies for Systems Biology, Early-Stage Research
"The new structure will provide a single interface through which Agilent can better serve its customers in basic research, drug discovery and early-stage drug development," said DiNuzzo, vice president and general manager of IBS. "It will enable the rapid development of products that bridge multiple disciplines, thereby facilitating a more integrative study of biological organisms often referred to as 'systems biology.' "
"We are firmly committed to the life sciences and serving our customers successfully across the entire pharmaceutical value chain," said Chris van Ingen, president of Agilent's Life Sciences and Chemical Analysis group. "By focusing on the needs of basic research and drug discovery scientists, the IBS unit will provide a direct complement to our Pharmaceutical Analysis unit, which focuses on later-stage drug development and manufacturing. Under the leadership of Fran DiNuzzo, I believe we can accelerate our life science growth and position Agilent as a much stronger player in systems biology and the fields it encompasses."
Pharmaceutical, biotech and academic customers use a combination of technologies to research disease and potential new drugs. The data obtained during research -- whether from RNA, DNA or proteins -- is applicable to the broader study of biological systems such as molecular pathways and cellular metabolism. But it has traditionally been very difficult to integrate these diverse technologies and the data they produce. Agilent's new business unit pulls these technologies and markets under the same leadership with an eye toward the development of more comprehensive and integrated customer solutions. The change does not affect Agilent's financial reporting.
Most read news
Topics
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.